Details
Stereochemistry | RACEMIC |
Molecular Formula | C8H11NO2.ClH |
Molecular Weight | 189.639 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NCC(O)C1=CC=C(O)C=C1
InChI
InChIKey=PUMZXCBVHLCWQG-UHFFFAOYSA-N
InChI=1S/C8H11NO2.ClH/c9-5-8(11)6-1-3-7(10)4-2-6;/h1-4,8,10-11H,5,9H2;1H
Octopamine is an organic chemical closely related to norepinephrine. In many types of invertebrates it functions as a neurotransmitter. Octopamine is known to exert adrenergic effects in mammals although specific octopamine receptors have been cloned only in invertebrates. It has been shown that octopamine can stimulate alpha(2)-adrenoceptors (ARs) in Chinese hamster ovary cells transfected with human alpha(2)-ARs. Octopamine stimulates lipolysis through beta(3)-rather than beta(1)-or beta(2)-AR activation in white adipocytes from different mammalian species. Octopamine activates only beta(3)-ARs and is devoid of alpha(2)-adrenergic agonism. Thus, octopamine could be considered as an endogenous selective beta(3)-AR agonist. In humans Octopamine is a trace amine found endogenously in the human brain where it interacts with signalling of catecholamines; it is structurally similar to synephrine and tyramine, being a metabolite of the latter (via dopamine β-hydroxylase) and substrate for the synthesis of the former (via phenethanolamine N-methyltransferase[3]) while being perhaps the closest in structure to noradrenaline. Octopamine is found in the bitter orange similar to many biogenic amines related to L-tyrosine that are used as dietary supplements, this includes synephrine and hordenine. p-Octopamine HCl (Norphen) was studied in the late
1960’s and 1970’s as a drug for the treatment of hypotensive
regulatory and circulatory disorders. Octopamine was used as a nootropic. All optical isomers (enantiomers) of octopamine are on the
World Anti-Doping Agency (WADA) 2014 list of substances
prohibited in competition.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10515667 | https://www.ncbi.nlm.nih.gov/pubmed/24654910
Curator's Comment: Octopamine (OA), a biogenic monoamine structurally related to noradrenaline, acts as a neurohormone, a neuromodulator and a neurotransmitter in invertebrates. The known actions of OA in the central nervous system include desensitization of sensory inputs, influence on learning and memory, or regulation of the 'mood' of the animal. In vertebrates p-Octopamine is considered to be a CNS stimulant in spite of the fact that it binds poorly to adrenergic receptors.
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
39.1 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4277715/ |
2 mg single, intravenous dose: 2 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
OCTOPAMINE serum | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
213 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4277715/ |
8 mg single, oral dose: 8 mg route of administration: Oral experiment type: SINGLE co-administered: |
OCTOPAMINE serum | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
243 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4277715/ |
2 mg single, intravenous dose: 2 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
OCTOPAMINE serum | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
175 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4277715/ |
8 mg single, oral dose: 8 mg route of administration: Oral experiment type: SINGLE co-administered: |
OCTOPAMINE serum | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
67% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/4277715/ |
OCTOPAMINE serum | Homo sapiens |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
OverviewOther
Other Inhibitor | Other Substrate | Other Inducer |
---|---|---|
Drug as perpetrator
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
Page: 1.0 |
inconclusive [IC50 0.1096 uM] | |||
Page: 127.0 |
inconclusive | |||
Page: 191.0 |
no | |||
Page: 181.0 |
no | |||
Page: 182.0 |
no | |||
Page: 179.0 |
no | |||
yes [Inhibition 10 uM] | ||||
yes [Inhibition 10 uM] |
Drug as victim
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
no | ||||
no | ||||
Page: 157 | 158 |
no | |||
yes |
Tox targets
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
Page: 47.0 |
PubMed
Title | Date | PubMed |
---|---|---|
Distribution and action of some putative neurotransmitters in the stomatogastric nervous system of the earthworm, Eisenia fetida (Oligochaeta, Annelida). | 2001 Apr |
|
Oscillations of the transepithelial potential of moth olfactory sensilla are influenced by octopamine and serotonin. | 2001 Aug |
|
Identification of novel inhibitors of calling and in vitro [14C]acetate incorporation by pheromone glands of Plodia interpunctella. | 2001 Aug |
|
Activation and reconfiguration of fictive feeding by the octopamine-containing modulatory OC interneurons in the snail Lymnaea. | 2001 Aug |
|
Amine modulation of the transient potassium current in identified cells of the lobster stomatogastric ganglion. | 2001 Dec |
|
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. | 2001 Dec |
|
Hormonal stimulation of proline synthesis in the fat body of the fruit beetle, Pachnoda sinuata, is calcium dependent. | 2001 Dec |
|
Inositol trisphosphate mediates the action of hypertrehalosemic hormone on fat body of the American cockroach, Periplaneta americana. | 2001 Dec |
|
Biogenic amines modulate olfactory receptor neurons firing activity in Mamestra brassicae. | 2001 Jul |
|
Effects of catecholamines on calvarial bone resorption in vitro. | 2001 Jul |
|
An in vitro method for recording the electrical activity of the isolated heart of the adult Drosophila melanogaster. | 2001 Jul-Aug |
|
Missing link in firefly bioluminescence revealed: NO regulation of photocyte respiration. | 2001 Nov |
|
Insecticidal activity of essential oils: octopaminergic sites of action. | 2001 Nov |
|
Apolipophorin-III in the greater wax moth, Galleria mellonella (Lepidoptera: Pyralidae). | 2001 Nov |
|
Regulation of the pharynx of Caenorhabditis elegans by 5-HT, octopamine, and FMRFamide-like neuropeptides. | 2001 Nov 15 |
|
Categorical and prolonged potentials are evoked when brief, intermediate-intensity flashes stimulate horseshoe crab lateral eye photoreceptors during octopamine neuromodulation. | 2001 Nov-Dec |
|
Presynaptic effects of biogenic amines modulating synaptic transmission between identified sensory neurons and giant interneurons in the first instar cockroach. | 2001 Oct |
|
Ontogeny of neurohormonal regulation of the cardiovascular system in the crayfish Procambarus clarkii. | 2001 Oct |
|
Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults. | 2001 Oct |
|
Dual action of octopamine on glucose transport into adipocytes: inhibition via beta3-adrenoceptor activation and stimulation via oxidation by amine oxidases. | 2001 Oct |
|
Serotonergic and octopaminergic systems in the squat lobster Munida quadrispina (Anomura, Galatheidae). | 2001 Oct 29 |
|
[Interaction of hormones in controlling reproductive function of Drosophila females under stressful conditions is genetically determined]. | 2001 Sep |
|
Molecular and pharmacological properties of insect biogenic amine receptors: lessons from Drosophila melanogaster and Apis mellifera. | 2001 Sep |
|
Modulating the modulators: parasites, neuromodulators and host behavioral change. | 2002 |
|
Modulation by 5-hydroxytryptamine of nicotinic acetylcholine responses recorded from an identified cockroach (Periplaneta americana) motoneuron. | 2002 Feb |
|
Neurotransmitters and neuropeptides in the brain of the locust. | 2002 Feb 1 |
|
Comparative effects of dehydropirlindole and other compounds on rat brain monoamine oxidase type A. | 2002 Jan |
|
Fictive locomotion induced by octopamine in the earthworm. | 2002 Jan |
|
Three-dimensional common-feature hypotheses for octopamine agonist 2-(arylimino)imidazolidines. | 2002 Jan |
|
Distribution and development of dopamine- and octopamine-synthesizing neurons in the medicinal leech. | 2002 Jan 7 |
|
Neurochemical fine tuning of a peripheral tissue: peptidergic and aminergic regulation of fluid secretion by Malpighian tubules in the tobacco hawkmoth M. sexta. | 2002 Jul |
|
A high-affinity octopamine transporter cloned from the central nervous system of cabbage looper Trichoplusia ni. | 2002 Mar 1 |
|
Dual signalling by different octopamine receptors converges on adenylate cyclase in Sf9 cells. | 2002 Mar 1 |
|
Three-dimensional common-feature hypotheses of inhibitors of calling behaviour and in vitro [14C]acetate incorporation by pheromone glands of Plodia interpunctella. | 2002 Nov |
|
Activation of octopaminergic receptors by essential oil constituents isolated from aromatic plants: possible mode of action against insect pests. | 2002 Nov |
|
Behavioural pharmacology of octopamine, tyramine and dopamine in honey bees. | 2002 Nov 15 |
|
Three-dimensional common-feature hypotheses for octopamine agonist arylethanolamines. | 2002 Oct |
|
Juvenile hormone and octopamine in the regulation of division of labor in honey bee colonies. | 2002 Sep |
|
Octopamine enhances moth olfactory responses to pheromones, but not those to general odorants. | 2002 Sep |
|
Characterization of a tyramine receptor from Caenorhabditis elegans. | 2002 Sep |
|
A trace amine, tyramine, functions as a neuromodulator in Drosophila melanogaster. | 2002 Sep 6 |
|
Molecular and functional characterization of an octopamine receptor from honeybee (Apis mellifera) brain. | 2003 Aug |
|
Functionally distinct dopamine and octopamine transporters in the CNS of the cabbage looper moth. | 2003 Feb |
|
Site-directed mutagenesis studies on the Drosophila octopamine/tyramine receptor. | 2003 Feb |
|
Central modulatory neurons control fuel selection in flight muscle of migratory locust. | 2003 Feb 15 |
|
Positive and negative modulation of Bombyx mori adenylate cyclase by 5-phenyloxazoles: identification of octopamine and tyramine receptor agonists. | 2003 Jan |
|
Octopaminergic modulation of synaptic transmission between an identified sensory afferent and flight motoneuron in the locust. | 2003 Jul 14 |
|
Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase. | 2003 Jun |
|
Elusive amines and primary headaches: historical background and prospectives. | 2003 May |
|
Metabolic flux analysis of the phenylpropanoid pathway in wound-healing potato tuber tissue using stable isotope-labeled tracer and LC-MS spectroscopy. | 2003 May |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24654910
Curator's Comment: Also was used orally In a study using a 150 mg octopamine sustained release
tablet to treat hypotension, the author recommended one or
two tablets before arising, and another tablet at night as
needed (Stucke, 1972). In a similar study (Braasch et al.,
1971), subjects received the octopamine sustained release
tablet three times daily. In both cases under the described
conditions, the product was reported to raise systolic blood
pressure by approximately 6 to14 mm Hg.
When 500 mg p-octopamine was infused intravenously over 30–40
minutes into human subjects, systolic blood pressure
increases of about 15 mm Hg were observed within 10
minutes. Intramuscular administration of
50 mg of a depo (slow release) form of p-octopamine into
humans resulted in similar increases in systolic blood pressure.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24654910
In isolated adipocytes from rats, the concentrations of 0.01–
0.10 nmol p-octopamine activated b-3 adrenergic receptors
to lower glucose uptake into adipocytes and increase cAMP.
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
20592
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY | |||
|
m8118
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY | Merck Index | ||
|
770-05-8
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY | |||
|
1744461
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY | |||
|
212-216-4
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY | |||
|
DTXSID8033803
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY | |||
|
SUB03488MIG
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY | |||
|
108685
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY | |||
|
100000085915
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY | |||
|
37YAS5L9HQ
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY | |||
|
37YAS5L9HQ
Created by
admin on Mon Mar 31 21:34:47 GMT 2025 , Edited by admin on Mon Mar 31 21:34:47 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD